-transparent.png){kind=logo}
Prolymphocytic leukemia is an entity characterized by morphologic, immunologic, clinical and behavioral features which allows its keeping apart from chronic lymphoid leukemia. Careful analysis of blood smear is the main step for its diagnosis. Our purpose is to remind this particular chronic lymphoproliferative syndrome which requires energetic initial treatment. Prolymphocytic leukemia de novo as well as a possible transformation of chronic lymphoid leukemia to prolymphocytic leukemia are discussed.
Related Publications
P Y Dietrich, and
E Pedraza, and
C Bayle, and
J L Pico, and
M Hayat
September 1981,
Nederlands tijdschrift voor geneeskunde,
P Y Dietrich, and
E Pedraza, and
C Bayle, and
J L Pico, and
M Hayat
April 1990,
Hematology/oncology clinics of North America,
P Y Dietrich, and
E Pedraza, and
C Bayle, and
J L Pico, and
M Hayat
June 1986,
[Rinsho ketsueki] The Japanese journal of clinical hematology,
P Y Dietrich, and
E Pedraza, and
C Bayle, and
J L Pico, and
M Hayat
July 1976,
Vnitrni lekarstvi,
P Y Dietrich, and
E Pedraza, and
C Bayle, and
J L Pico, and
M Hayat
January 1989,
Acta haematologica Polonica,
P Y Dietrich, and
E Pedraza, and
C Bayle, and
J L Pico, and
M Hayat
February 1985,
Gematologiia i transfuziologiia,
P Y Dietrich, and
E Pedraza, and
C Bayle, and
J L Pico, and
M Hayat
May 2005,
Current treatment options in oncology,
P Y Dietrich, and
E Pedraza, and
C Bayle, and
J L Pico, and
M Hayat
January 1992,
Duodecim; laaketieteellinen aikakauskirja,
P Y Dietrich, and
E Pedraza, and
C Bayle, and
J L Pico, and
M Hayat
July 1978,
Klinische Wochenschrift,
P Y Dietrich, and
E Pedraza, and
C Bayle, and
J L Pico, and
M Hayat
May 1978,
Nihon rinsho. Japanese journal of clinical medicine,
